FDA-LIVE-CASE › Live Case Presentations During Investigational Device Exemption (IDE) Clinical Trials - Draft Guidance for Institutional Review Boards, Industry, Investigators, and Food and Drug Administration Staff
Live Case Presentations During Investigational Device Exemption (IDE) Clinical Trials - Draft Guidance for Institutional Review Boards, Industry, Investigators, and Food and Drug Administration Staff
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Document Number
FDA-LIVE-CASE
Revision Level
2019 EDITION
Status
Current
Publication Date
July 11, 2019
Page Count
15 pages